Understanding how peripheral immune activity shapes brain structure is a central challenge in contemporary neuropsychiatry. Over the past decades, numerous studies have documented robust associations between peripheral inflammatory signals and structural or functional alterations in the brain.1 However, these findings have largely been derived from observational frameworks that cannot resolve whether inflammation actively drives neural changes, merely reflects ongoing brain pathology, or co-varies with disease due to shared genetic or environmental influences. As a result, peripheral inflammation and central neurobiological alterations have often been discussed in parallel rather than within a defined causal hierarchy,2 limiting the field's ability to move from description toward mechanism. The study by Yang et al.3 offers a decisive advance in addressing a longstanding limitation in neuroimmunology: the inability to move from association to causation. By applying bidirectional Mendelian randomization (MR) to large-scale genetic datasets, the authors provide the first systematic evidence that multiple circulating inflammatory factors exert causal effects on white matter microstructure. Their analysis identifies 21 cytokines with directional influences on specific fiber tracts, enabling a clearer distinction between inflammatory signals that function as upstream drivers of structural brain alterations and those that reflect downstream or parallel disease processes. Notably, the protective effects associated with anti-inflammatory mediators such as granulocyte colony-stimulating factor (G-CSF) highlight the biological specificity and translational relevance of these findings. In addition, reverse MR yielded only two significant results, underscoring the predominant directional influence of peripheral inflammation on brain microstructure while still affirming the bidirectional nature of brain–immune interactions. The significance of this work extends well beyond the discovery of additional immune–brain associations. It effectively constructs a high-resolution causal hypothesis map, transforming the previously diffuse concept of an ‘inflammatory-brain axis’ into a set of concrete, testable molecular–anatomical pathways, exemplified by links such as interleukin-9 (IL-9) signaling and the integrity of the genu of the corpus callosum. In doing so, the study demonstrates how genetic epidemiology can serve as a critical bridge between correlation and causation in domains where direct experimental manipulation is impractical. By anchoring immune–brain interactions within a causal inference framework, this work advances a paradigm shift in neuroimmunology research. It sharpens mechanistic understanding of inflammation-related white matter vulnerability in neuropsychiatric disorders while also pointing toward candidate biomarkers and immunomodulatory targets for early intervention and disease monitoring. At the same time, the findings delineate the limits of genetic inference. MR clarifies whether inflammation contributes to structural brain variation, but it does not specify the cellular and molecular mechanisms through which cytokine signals act within the central nervous system. The pathways linking circulating cytokines to blood–brain barrier dynamics, microglial activation, oligodendrocyte lineage regulation, and myelin integrity remain to be elucidated (Fig. 1). Moreover, genetic liability reflects long-term average effects, whereas neuroinflammatory processes are spatially and temporally dynamic across brain regions and disease stages. Within this context, the causal map defined by Yang et al. offers a strategic framework for future research that integrates genetic inference with longitudinal neuroimaging, experimental models, and clinical studies. Such integrative approaches are well positioned to clarify when, where, and how immune signaling reshapes vulnerable white matter circuits and to support the development of targeted, time-sensitive immunomodulatory strategies for neuropsychiatric disorders. We acknowledge the support by the National Key R&D Program of China (2024YFA1306900).
Guan et al. (2026) studied this question.